SNOT-22 in a control population

Sally Erskine; Claire Hopkins; Allan Clark; Shahram Anari; Nirmal Kumar; Alasdair Robertson; Vishnu Sunkaraneni; J. A. Wilson; Sean Carrie; Naveed Kara; Jaydip Ray; R. Smith; Carl Philpott; CRES group

doi:10.1111/coa.12667

SNOT-22 in a control population

Sally Erskine, Claire Hopkins, Allan Clark, Shahram Anari, Nirmal Kumar, Alasdair Robertson, Vishnu Sunkaraneni, J. A. Wilson, Sean Carrie, Naveed Kara, Jaydip Ray, R. Smith, Carl Philpott, CRES group

Research output: Contribution to journal › Article › peer-review

26 Citations (Scopus)

27 Downloads (Pure)

Abstract

AIM: To assess SNOT-22 and its subscales in a non-rhinosinusitis UK-wide population.

METHODOLOGY/PRINCIPLE: This analysis uses data from the 'Chronic Rhinosinusitis Epidemiology Study' (CRES) which recruited from 30 centres across the UK, and the Socioeconomic Cost of ChrOnic Rhinosinusitis study' (SocCoR); 250 volunteers without CRS were recruited as part of these studies. Study-specific questionnaires including demographics, socioeconomic factors and past medical history as well as SNOT-22 and SF-36 were distributed. The control (non-CRS) population had no self-reported nasal problems in the past, no chronic conditions undergoing active treatment and no hospital admissions in the preceding 12 months.

RESULTS: The mean SNOT-22 total score overall was 12.0. The mean was 10.2 for males with a median of 6.5, and a mean of 13.2 for females with a median of 9. Females scored significantly more highly than males on the sleep/fatigue and facial domains.

CONCLUSIONS: Our data demonstrate differences in SNOT-22 amongst males and females. These data can be used in future studies for comparison with different disease populations with rhinosinusitis. This article is protected by copyright. All rights reserved.

Original language	English
Pages (from-to)	81–85
Number of pages	5
Journal	Clinical Otolaryngology
Volume	42
Issue number	1
Early online date	5 May 2016
DOIs	https://doi.org/10.1111/coa.12667
Publication status	Published - Feb 2017

Keywords

Sinonasal Outcome Test
Control population

Access to Document

10.1111/coa.12667

ManuscriptAccepted author manuscript, 349 KB

1 Finished

Clinical Senior Lectureship - Clinical Research Ear, Nose and Throat
Fraser, W., Harvey, I. & Philpott, C.
James Paget University Hospitals NHS Foundation Trust
1/01/10 → 31/03/20
Project: Research

26 Citations (Scopus)
5 Article

Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study
Philpott, C., Smith, R., Davies-Husband, C., Erskine, S., Clark, A., Welch, A., Hopkins, C., Carrie, S., Ray, J., Sunkaraneni, V., Kara, N., Kumar, N., Robertson, A., Anari, S., Almeyda, R., Wilson, A. & CRES group, Jun 2019, In: Rhinology. 57, 4, p. 303-312 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File

9 Citations (Scopus)

23 Downloads (Pure)
Current use of baseline medical treatment in chronic rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study (CRES)
Philpott, C., Erskine, S., Smith, R., Hopkins, C., Kara, N., Farboud, A., Salam, M., Robertson, A., Almeyda, R., Kumar, B. N., Anari, S., Ray, J., Cathcart, R., Carrie, S., Ahmed, S., Khalil, H., Clark, A. & Thomas, M., Apr 2018, In: Clinical Otolaryngology. 43, 2, p. 509–524 16 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File

17 Citations (Scopus)

18 Downloads (Pure)
A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
Philpott, C., Erskine, S., Hopkins, C., Coombes, E., Kara, N., Sunkaraneni, V., Anari, S., Salam, M., Farboud, A. & Clark, A., 2016, In: Rhinology. 54, 2, p. 134-140 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File

CRES Dataset
Philpott, C. (Creator), Dryad data repository, 2017
DOI: 10.5061/dryad.kt32c
Dataset

Cite this

@article{1c31c406342a430ba02022f3372a9711,

title = "SNOT-22 in a control population",

abstract = "AIM: To assess SNOT-22 and its subscales in a non-rhinosinusitis UK-wide population. METHODOLOGY/PRINCIPLE: This analysis uses data from the 'Chronic Rhinosinusitis Epidemiology Study' (CRES) which recruited from 30 centres across the UK, and the Socioeconomic Cost of ChrOnic Rhinosinusitis study' (SocCoR); 250 volunteers without CRS were recruited as part of these studies. Study-specific questionnaires including demographics, socioeconomic factors and past medical history as well as SNOT-22 and SF-36 were distributed. The control (non-CRS) population had no self-reported nasal problems in the past, no chronic conditions undergoing active treatment and no hospital admissions in the preceding 12 months. RESULTS: The mean SNOT-22 total score overall was 12.0. The mean was 10.2 for males with a median of 6.5, and a mean of 13.2 for females with a median of 9. Females scored significantly more highly than males on the sleep/fatigue and facial domains. CONCLUSIONS: Our data demonstrate differences in SNOT-22 amongst males and females. These data can be used in future studies for comparison with different disease populations with rhinosinusitis. This article is protected by copyright. All rights reserved. ",

keywords = "Sinonasal Outcome Test, Control population",

author = "Sally Erskine and Claire Hopkins and Allan Clark and Shahram Anari and Nirmal Kumar and Alasdair Robertson and Vishnu Sunkaraneni and Wilson, {J. A.} and Sean Carrie and Naveed Kara and Jaydip Ray and R. Smith and Carl Philpott and {CRES group} and Steve Morris and Shahzada Ahmed and Paul Jervis and Jaan Panesaar and Amir Farboud and Russell Cathcart and Robert Almeyda and Hisham Khalil and Peter Prinsley and Nicolas Mansell and Mahmoud Salam and Jonathan Hobson and Jane Woods and Emma Coombes",

note = "This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/coa.12667",

year = "2017",

month = feb,

doi = "10.1111/coa.12667",

language = "English",

volume = "42",

pages = "81–85",

journal = "Clinical Otolaryngology",

issn = "1749-4478",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - SNOT-22 in a control population

AU - Erskine, Sally

AU - Hopkins, Claire

AU - Clark, Allan

AU - Anari, Shahram

AU - Kumar, Nirmal

AU - Robertson, Alasdair

AU - Sunkaraneni, Vishnu

AU - Wilson, J. A.

AU - Carrie, Sean

AU - Kara, Naveed

AU - Ray, Jaydip

AU - Smith, R.

AU - Philpott, Carl

AU - CRES group

AU - Morris, Steve

AU - Ahmed, Shahzada

AU - Jervis, Paul

AU - Panesaar, Jaan

AU - Farboud, Amir

AU - Cathcart, Russell

AU - Almeyda, Robert

AU - Khalil, Hisham

AU - Prinsley, Peter

AU - Mansell, Nicolas

AU - Salam, Mahmoud

AU - Hobson, Jonathan

AU - Woods, Jane

AU - Coombes, Emma

N1 - This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/coa.12667

PY - 2017/2

Y1 - 2017/2

N2 - AIM: To assess SNOT-22 and its subscales in a non-rhinosinusitis UK-wide population. METHODOLOGY/PRINCIPLE: This analysis uses data from the 'Chronic Rhinosinusitis Epidemiology Study' (CRES) which recruited from 30 centres across the UK, and the Socioeconomic Cost of ChrOnic Rhinosinusitis study' (SocCoR); 250 volunteers without CRS were recruited as part of these studies. Study-specific questionnaires including demographics, socioeconomic factors and past medical history as well as SNOT-22 and SF-36 were distributed. The control (non-CRS) population had no self-reported nasal problems in the past, no chronic conditions undergoing active treatment and no hospital admissions in the preceding 12 months. RESULTS: The mean SNOT-22 total score overall was 12.0. The mean was 10.2 for males with a median of 6.5, and a mean of 13.2 for females with a median of 9. Females scored significantly more highly than males on the sleep/fatigue and facial domains. CONCLUSIONS: Our data demonstrate differences in SNOT-22 amongst males and females. These data can be used in future studies for comparison with different disease populations with rhinosinusitis. This article is protected by copyright. All rights reserved.

AB - AIM: To assess SNOT-22 and its subscales in a non-rhinosinusitis UK-wide population. METHODOLOGY/PRINCIPLE: This analysis uses data from the 'Chronic Rhinosinusitis Epidemiology Study' (CRES) which recruited from 30 centres across the UK, and the Socioeconomic Cost of ChrOnic Rhinosinusitis study' (SocCoR); 250 volunteers without CRS were recruited as part of these studies. Study-specific questionnaires including demographics, socioeconomic factors and past medical history as well as SNOT-22 and SF-36 were distributed. The control (non-CRS) population had no self-reported nasal problems in the past, no chronic conditions undergoing active treatment and no hospital admissions in the preceding 12 months. RESULTS: The mean SNOT-22 total score overall was 12.0. The mean was 10.2 for males with a median of 6.5, and a mean of 13.2 for females with a median of 9. Females scored significantly more highly than males on the sleep/fatigue and facial domains. CONCLUSIONS: Our data demonstrate differences in SNOT-22 amongst males and females. These data can be used in future studies for comparison with different disease populations with rhinosinusitis. This article is protected by copyright. All rights reserved.

KW - Sinonasal Outcome Test

KW - Control population

U2 - 10.1111/coa.12667

DO - 10.1111/coa.12667

M3 - Article

C2 - 27147284

VL - 42

SP - 81

EP - 85

JO - Clinical Otolaryngology

JF - Clinical Otolaryngology

SN - 1749-4478

IS - 1

ER -

SNOT-22 in a control population

Abstract

Keywords

Access to Document

Projects

Clinical Senior Lectureship - Clinical Research Ear, Nose and Throat

Research output

Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study

Current use of baseline medical treatment in chronic rhinosinusitis: Data from the National Chronic Rhinosinusitis Epidemiology Study (CRES)

A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis

Datasets

CRES Dataset

Cite this